Next Article in Journal
Insights into COVID-19 and Its Potential Implications for Kidney Dysfunction
Previous Article in Journal
A Concise Review of Prodigious Salinomycin and Its Derivatives Effective in Treatment of Breast Cancer: (2012–2022)
Previous Article in Special Issue
Malaria and HIV Co-Infection among Pregnant Women in Africa: Prevalence, Effect on Immunity and Clinical Management: Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Using the Theory of Planned Behavior and Past Behavior to Explain the Intention to Receive a Seasonal Influenza Vaccine among Family Caregivers of People with Dementia

1
Association for Neurogenetic Research (ARN), 88046 Lamezia Terme, Italy
2
Laboratory of Ancient DNA, Department of Cultural Heritage, University of Bologna, 48121 Ravenna, Italy
3
Laboratory of Molecular Anthropology and Center for Genome Biology, Department of Biological, Geological and Environmental Sciences, University of Bologna, 40126 Bologna, Italy
4
Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, 88046 Lamezia Terme, Italy
*
Authors to whom correspondence should be addressed.
A.C.B. is former Director of the Regional Neurogenetic Centre (CRN).
Int. J. Transl. Med. 2023, 3(2), 246-254; https://doi.org/10.3390/ijtm3020017
Submission received: 14 April 2023 / Revised: 11 May 2023 / Accepted: 17 May 2023 / Published: 19 May 2023

Abstract

:
Older adults with dementia present an increased risk of mortality due to seasonal influenza. Despite concerning evidence, the influenza vaccination program has been unsuccessful, with low rates of uptake in Italian people ≥65 years. In addition, being vaccinated does not eliminate the risk of contracting a virus, especially by coming into close contact with other possibly unvaccinated people, such as family caregivers in the home environment. Therefore, the refusal of family caregivers to get vaccinated for seasonal influenza could have dire consequences for their relatives with dementia. The aims of this study were to investigate the predictive role of the Theory of Planned Behavior model (TPB) and past vaccination behavior on the intention to receive a seasonal influenza vaccine among family caregivers of people with dementia. Data were collected from seventy-one respondents during July–September 2021 using a cross-sectional web-based survey design. Results of hierarchical binary logistic regression showed that TPB (i.e., attitudes towards vaccination, subjective norms, and perceived behavioral control) explained 51.6% of the variance in intention to receive a seasonal influenza vaccine; past vaccination behavior increased this to 58.8%. In conclusion, past vaccination behavior and the theory of planned behavior variables effectively predict influenza vaccine willingness of family caregivers of people with dementia and should be targeted in vaccination campaigns.

1. Introduction

Dementias represent a complex of chronic-degenerative pathologies characterized by progressive cognitive deficits [1]—such as memory, language, attention, and visuospatial and executive function impairments—behavioral disturbances [2,3]—such as apathy, depression, irritability, agitation, aggression, delusions, and hallucinations—and functional decline [4]. These clinical features could lead to the loss of autonomy and self-sufficiency and consequent dependence on others both for basic (e.g., dressing, eating, toileting, bathing, mobility) and instrumental (e.g., managing finances, cooking and meal preparation, medical management, transportation) activities of daily life [4]. Some types of dementia are classifiable as “primary” (e.g., Alzheimer’s disease, dementia with Lewy bodies, frontotemporal dementia) and others as “secondary” to other conditions (e.g., vascular dementia) [5]. Although most cases of dementia are sporadic—the causes of which have not yet been fully understood—there are also forms with a high familial recurrence and/or with autosomal dominant transmission of causative mutations from the parent to the offspring [6,7,8,9,10]. The prevalence of dementia is on the rise in the general population, and this evidence prompted the World Health Organization and Alzheimer Disease International to consider dementia as a global public health priority [11].
Family caregivers are all family members who assist a relative affected by dementia. Their task is to take charge of the daily person’s well-being, both from a physical (e.g., cleaning and hygiene, meals, medications), practical (e.g., providing medication, organizing medical examinations and rehabilitations), and emotional (e.g., provide support, stimulate patients to have conversations, entertain them with games, films, reading) point of view [12]. The commitment required by care can lead to the development of psychological distress (e.g., depressive symptoms) or caregiver burden [13].
Seasonal influenza is a contagious respiratory disease, caused by influenza viruses, which is contracted following contact with the saliva or respiratory secretions of infected individuals, due to coughing, sneezing or even simply the action of talking [14]. It can also be contracted via touching contaminated objects followed by hand contact with the mouth, nose, or eyes [15]. The typical symptoms of seasonal influenza include fever, cough, runny nose, sore throat, chills, and joint and muscle pain [14,16]. In some cases, especially when the virus affects infants, vomiting and diarrhea may occur. In others, especially older people, there may be weakness, fatigue, and confusion [17], with an increased hospitalization rate [18]. Rosano and colleagues [19] reported that Italy showed a higher excess mortality attributable to seasonal influenza when compared to other European countries. In addition, other studies showed that older adults with dementia tend to die more often from seasonal influenza [20]. Evidence suggests that the seasonal influenza vaccines have a moderate preventive effect among elderly people and that it significantly decreases the morbidity of seasonal influenza and pneumonia—which represent a primary cause of complications and mortality in people affected by dementia [21]—as well as the risk of hospitalization and death (World Health Organization Report on Influenza Vaccine Use, http://www.who.int/influenza/vaccines/use/en/, accessed on 3 April 2023) [22,23,24].
Therefore, to prevent the spread and the negative consequences of seasonal influenza, the Italian Ministry of Health recommends and offers free-of-charge vaccination against these viruses to people aged 60 years and older and other risk groups (https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2022&codLeg=87997&parte=1%20&serie=null, last accessed on 3 April 2023). Despite this, the influenza vaccination program has been unsuccessful, with low rates of uptake in Italian people ≥65 years [25]. In addition, being vaccinated does not completely eliminate the risk of contracting a virus, especially by coming into close contact with other and/or unvaccinated people [26,27] such as family caregivers in the home environment. Therefore, the refusal of family caregivers to get vaccinated for seasonal influenza could have consequences, even lethal, for their relatives with dementia [28].
Given that currently no definite cure exists for dementia, family caregivers have a low expectation about the therapeutic benefits of drug treatments for dementia [29]. This aspect could also influence their general view about drugs and vaccines efficacy [28], and therefore may affect their choice to receive a seasonal influenza vaccine. Therefore, it is necessary to identify the factors that influence the family caregivers’ choice to receive a seasonal influenza vaccine in order to promote more targeted vaccination campaigns.
The theory of planned behavior (TPB), proposed by Ajzen [30], represents an important theoretical model used to predict an individual’s behavior in terms of intention to get vaccinated [31,32]. This theory postulates that intentions are the most proximal determinants of behavior and that three factors converge to predict intentions [33]: (i) attitudes (i.e., the psychological tendency to evaluate a particular entity as favorable or unfavorable); (ii) subjective norms (i.e., the perceived expectations of significant others and motivation to conform to these expectations in relation to a particular behavior); (iii) and perceived behavioral control (i.e., the perception of how easy or difficult it is to perform a particular behavior) [34]. The TPB model was successfully used to predict the intention to receive a vaccine in other groups, such as the adult general population [32,35,36], older adults [37], students [38,39], pregnant women [40], and cancer patients [34]. Moreover, Ball and colleagues [41] developed a vaccine campaign based on the TPB model, namely the Shot Talk, which has proven useful in reducing COVID-19 vaccine hesitancy among college students.
In the context of TPB, other evidence suggests that past behaviors were also predictive of corresponding future behaviors [42,43,44]. More specifically, it has been shown that past history of seasonal influenza vaccine could be an additive prediction of future intention to receive it again [45,46,47,48]. Therefore, it is interesting to explore the impact of the TPB beyond past vaccination behavior.
Based on these premises, the aims of this study were to investigate the predictive role of the TPB model (i.e., attitudes towards vaccination, subjective norms, and perceived behavioral control) and past vaccination behavior on the intention to receive a seasonal influenza vaccine among family caregivers of people with dementia. We hypothesize that lower negative attitudes towards vaccines, higher subjective norms, and higher perceived behavioral control predict the intention to receive a seasonal influenza vaccine among family caregivers of people with dementia (H1). Past seasonal influenza vaccination behavior could also add to the understanding of intention beyond the TPB model (H2).

2. Materials and Methods

2.1. Participants and Procedure

Data were obtained from seventy-one family caregivers of patients with dementia. Contact information on family caregivers was obtained from the Regional Neurogenetic Centre—ASPCZ (Lamezia Terme, Catanzaro, Italy). The CRN aims to carry out research and provide assistance to people affected by neurodegenerative diseases. In its almost 30 years of activity, it has become a point of reference for patients and family caregivers, not only for the Calabrian provinces, but also for other Italian regions (see http://www.arn.it/it/crn/, accessed on 3 May 2023) [49]. To perform the present study, a cross-sectional web-based survey design was adopted to limit face-to-face contacts due to the COVID-19 pandemic, using the free software Google Forms®. The online survey was distributed between July and September of 2021. We used a forced response strategy to avoid missing data. An informational letter about the purpose of the study was mailed to all participants, along with a link to the questionnaires. Individuals were informed that participation in the study was voluntary, the survey was anonymous, and they could withdraw from the study at any time. The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethical Committee of Calabria Region (Catanzaro, Italy; protocol code 52098, 16 April 2021).

2.2. Measures

Socio-demographics and clinical factors. Questions about sociodemographic characteristics were asked to family caregivers at the end of the survey. Specifically, participants reported the gender, age, educational level, marital status, employment status, and economic condition of the family member with dementia, as well as themselves. Family caregivers also answered questions related to the clinical conditions of their family members affected by dementia (i.e., type of diagnosis, year of diagnosis, and current disease stage).
Attitudes towards vaccination. Attitudes toward vaccination were evaluated using the Italian version of the Vaccination Attitudes Examination Scale (VAX-I scale) [50]. It consists of 12 items which can be divided into four subscales (mistrust of vaccine benefit, worries about unforeseen future effects, concerns about commercial profiteering, and preference for natural immunity), each indicated by three items. All items are presented in the form of a statement, with responses on a 6-point Likert-type scale ranging from 1 (strongly disagree) to 6 (strongly agree). Higher scores on each subscale reflect stronger anti-vaccination attitudes. In our sample, internal consistency was good; Cronbach’s was: α = 0.89 for mistrust of vaccine benefit, α = 0.71 for concerns about commercial profiteering, α = 0.88 for preference for natural immunity, and α = 0.91 for worries about unforeseen future effects.
Subjective norms. Subjective norms were measured using six items rated on a 5-point Likert-type scale, ranging from 1 (strongly disagree) to 5 (strongly agree), adapted from a previous study [34]. An example item is “People who are important to me want me to have seasonal influenza vaccine”. Items were averaged to create the composite, with higher scores reflecting norms favoring vaccination. The scale showed an adequate internal consistency α = 0.70.
Perceived behavioral control. Perceived behavioral control was measured with four items rated on a 5-point Likert-type scale ranging from 1 (strongly disagree) to 5 (strongly agree) adapted from a previous study [34]. A sample item is “I am confident that I will be able to easily get the seasonal vaccine when it becomes available”. Items were averaged to create the composite, with higher scores reflecting greater confidence in one’s ability to obtain the vaccine. The scale showed a good internal reliability (α = 0.82).
Past vaccination behavior. Respondents were asked whether they had received any seasonal influenza vaccination in the past three years (yes/no).
Intention to get a seasonal vaccine. Intention to get a seasonal vaccine was measured by asking participants the following question: “I intend to have the anti-seasonal vaccine when it becomes available” (yes/no), according to a previous study [28].

2.3. Statistical Analysis

Data were analyzed in the Jamovi software (version 2.3.18). Descriptive statistics were used for demographic and clinical variables. To explore and identify the factors related to the intention to receive a seasonal influenza vaccine, correlations followed by a hierarchical binary logistic regression analysis were used, with odds ratios (ORs) and 95% confidence intervals (CIs). “The intention to receive a seasonal influenza vaccine” was entered as the outcome variable, and predictors were selected a priori based on their correlations with the criterion (concerns about commercial profiteering, subjective norms, perceived behavioral control and past vaccination behavior). These variables were divided into two blocks: TPB variables were entered into the first block, and the past vaccination behavior into the second block, according to the theoretical background discussed above.

3. Results

Participants Characteristics

Descriptive characteristics of the respondents and their familial affected by dementia are provided in Table 1 and Table 2, respectively. The sample was composed of seventy-one family caregivers of people with dementia (70.4% female, mean age: 55.9 ± 12.5). Most of these were unemployed (53.5%), had a low level of school education (66.2%), and standard economic conditions (54.9%). Most patients were affected by Alzheimer’s disease (67.6) followed by frontotemporal dementia (16.9%).
It is evident from Table 3 that the intention to receive the seasonal influenza vaccine among family caregivers was significantly associated with concerns about commercial profiteering, r = −0.285 *, p < 0.05—with family caregivers who were more concerned about commercial profiteering less likely to be vaccinated—subjective norms, r = 0.323 **, p < 0.01—with family caregivers with higher subjective norms more likely to be vaccinated, perceived behavioral control, r = 0.362 **, p < 0.01—with family caregivers with higher perceived behavioral control more likely to be vaccinated, and past vaccination behavior r = 0.790, p < 0.001—with family caregivers who received a seasonal influenza vaccine in the previous three years more likely to be vaccinated.
A hierarchical binary logistic regression analysis was conducted to determine the influence of TPB variables and past vaccination behavior on the intention to receive a seasonal influenza vaccine (Table 4). Our first model, which included TPB variables (Table 4; model 1), i.e., attitudes towards vaccine (i.e., concerns about commercial profiteering), perceived behavioral control, and subjective norms, explained 51.6% of the variance in intention to receive a seasonal influenza vaccine (adjusted R2 = 0.516). According to this model, concerns about commercial profiteering were negatively associated with the intention to receive seasonal influenza vaccine (OR = 0.73, 95% CI 0.55–0.96). Conversely, we have found a positive association between the intention to receive the seasonal influenza vaccine and subjective norms (OR = 1.27, 95% CI 1.01–1.61) and perceived behavioral control (OR = 1.66, 95% CI 1.0–2.51). The second model considered in this study, which included TPB variables, as well as the past vaccination behavior (Table 4; model 2), explained 58.8% of the variance in intention to receive a seasonal influenza vaccine (adjusted R2 = 0.588). Past vaccination behavior was associated with a 2.28-times greater likelihood of receiving a seasonal influenza vaccine (OR = 2.28, 95% CI 1.01–5.13). Past vaccination behavior, concerns about commercial profiteering, subjective norms, and perceived behavioral control were all significant predictors of the intention to receive a seasonal influenza vaccine.

4. Discussion

To our knowledge, this study represents the first attempt in the international literature to identify factors associated with the intention to receive a seasonal influenza vaccine among family caregivers of people with dementia. Based on previous findings on other populations [34,43,45], we hypothesized that the TPB model and past history of seasonal influenza vaccines would predict the intention to receive a seasonal influenza vaccine also in our subject group. The analysis confirmed the hypothetical–theoretical model. Results of the hierarchical logistic regression showed that TPB (i.e., attitudes towards vaccination, subjective norms, and perceived behavioral control) explained 51.6% of the variance in intention to receive a seasonal influenza vaccine. Accordingly, it has been reported that the TPB model explained 51.7% [38] and 44% [35] of variance in seasonal vaccine intentions among college students and the UK adult general population, respectively.
In addition, our results demonstrated that the extension of the TBP model with past vaccination behavior increased the explained variance in the intention to receive a seasonal influenza vaccine among family caregivers of people with dementia to 58.8%. In particular, this intention was positively associated with past seasonal influenza vaccine behavior, followed by perceived behavioral control and subjective norms, and negatively associated with concerns about commercial profiteering. These findings suggested that it could be helpful to involve family caregivers who have received a seasonal influenza vaccine in previous years in vaccination campaigns, to share directly with their peers the advantages and disadvantages associated with this behavior. As mentioned above, concerns about commercial profiteering were negatively associated with the intention to receive a seasonal influenza vaccine, indicating that family caregivers who were more wary of the influence of the powerful pharmaceutical companies in the development and deployment of vaccines are less intentioned to get a seasonal influenza vaccine. These results are in line with the study of Paul and colleagues [51], who found that this attitude was one of the most important determinants of uncertainty and unwillingness to vaccinate against COVID-19 in a large sample of UK adults.
Future vaccination campaigns might try to address the concerns about economic profits to increase the rate of seasonal vaccination in family caregivers of people with dementia. Moreover, the Shot Talk campaign proposed by Ball and colleagues [41] has been found to be useful in increasing perceived behavioral control and subjective norms and in improving attitudes towards vaccines among college students. Future research should evaluate the effectiveness of such a campaign to reduce the rate of vaccine hesitancy among family caregivers of people with dementia in the perspective of the TPB model.
This research has several limitations. First, it is necessary to underline that the use of a convenience sample has potentially increased the likelihood of bias. In future research, it would be more appropriate to use random sampling techniques to enhance the internal validity of the study. Second, the dimensions of this study were assessed using self-reported measures. Future research should take into consideration different methods to reduce the influence of self-report bias. Finally, a longitudinal design would be ideal to understand whether the TPB model also predicts the shift of vaccine intention into behavior in this population.

5. Conclusions

To decrease the negative consequences of seasonal influenza in people with dementia, it could be useful to promote seasonal influenza vaccinations also amongst their family caregivers, with whom they spend most of their time. Past vaccination behavior and the theory of planned behavior variables effectively predict influenza vaccine willingness in family caregivers of people with dementia and should be targeted in vaccination campaigns.

Author Contributions

Conceptualization, F.B. and P.A.; methodology, F.B. and P.A.; formal analysis, F.B. and P.A.; data collection, V.L., R.C., S.M.C., F.F. and G.P.; data curation, F.B. and P.A.; writing—original draft preparation, F.B. and P.A.; writing—review and editing, R.D.L., A.C.B. and R.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethical Committee of Calabria Region (Catanzaro, Italy; protocol code 52098, 16 April 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Prado, C.E.; Watt, S.; Treeby, M.S.; Crowe, S.F. Performance on neuropsychological assessment and progression to dementia: A meta-analysis. Psychol. Aging 2019, 34, 954–977. [Google Scholar] [CrossRef] [PubMed]
  2. Altomari, N.; Bruno, F.; Laganà, V.; Smirne, N.; Colao, R.; Curcio, S.; Di Lorenzo, R.; Frangipane, F.; Maletta, R.; Puccio, G.; et al. A comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD sub-syndromes in early-onset and late-onset Alzheimer’s Disease. J. Alzheimer’s Dis. 2022, 85, 691–699. [Google Scholar] [CrossRef] [PubMed]
  3. Laganà, V.; Bruno, F.; Altomari, N.; Bruni, G.; Smirne, N.; Curcio, S.; Mirabelli, M.; Colao, R.; Puccio, G.; Frangipane, F.; et al. Neuropsychiatric or Behavioral and Psychological Symptoms of Dementia (BPSD): Focus on prevalence and natural history in Alzheimer’s Disease and Frontotemporal Dementia. Front. Neurol. 2022, 13, 832199. [Google Scholar] [CrossRef] [PubMed]
  4. Cipriani, G.; Danti, S.; Picchi, L.; Nuti, A.; Di Fiorino, M. Daily functioning and dementia. Dement. Neuropsychol. 2020, 14, 93–102. [Google Scholar] [CrossRef]
  5. Salardini, A. An overview of primary dementias as clinicopathological entities. Semin. Neurol. 2019, 39, 153–166. [Google Scholar] [CrossRef] [PubMed]
  6. Loy, C.T.; Schofield, P.R.; Turner, A.M.; Kwok, J.B. Genetics of dementia. Lancet 2014, 383, 828–840. [Google Scholar] [CrossRef] [PubMed]
  7. Bruno, F.; Malvaso, A.; Canterini, S.; Bruni, A.C. Antimicrobial Peptides (AMPs) in the pathogenesis of Alzheimer’s Disease: Implications for diagnosis and treatment. Antibiotics 2022, 11, 726. [Google Scholar] [CrossRef] [PubMed]
  8. Bruno, F.; Conidi, M.E.; Puccio, G.; Frangipane, F.; Laganà, V.; Bernardi, L.; Smirne, N.; Mirabelli, M.; Colao, R.; Curcio, S.; et al. A novel mutation (D395A) in Valosin-containing protein gene is associated with early onset frontotemporal dementia in an Italian family. Front. Genet. 2021, 12, 795029. [Google Scholar] [CrossRef] [PubMed]
  9. Abondio, P.; Sarno, S.; Giuliani, C.; Laganà, V.; Maletta, R.; Bernardi, L.; Bruno, F.; Colao, R.; Puccio, G.; Frangipane, F.; et al. Amyloid precursor protein A713T mutation in Calabrian patients with Alzheimer’s Disease: A population genomics approach to estimate inheritance from a common ancestor. Biomedicines 2021, 10, 20. [Google Scholar] [CrossRef]
  10. Abondio, P.; Bruno, F.; Bruni, A.C.; Luiselli, D. Rare amyloid precursor protein point mutations recapitulate worldwide migration and admixture in healthy individuals: Implications for the study of neurodegeneration. Int. J. Mol. Sci. 2022, 23, 15871. [Google Scholar] [CrossRef]
  11. Wortmann, M. Dementia: A global health priority—Highlights from an ADI and World Health Organization report. Alzheimer’s Res. Ther. 2012, 4, 40. [Google Scholar] [CrossRef] [PubMed]
  12. Borella, E.; Faggian, S. Sostenere Chi Sostiene: Strumenti e Eindicazioni Per Supportare Chi si Occupa di Persone con Demenza; Angeli, F., Ed.; FrancoAngeli: Milano, Italy, 2019; ISBN 978-88-917-8155-0. [Google Scholar]
  13. Cheng, S.-T. Dementia caregiver burden: A research update and critical analysis. Curr. Psychiatry Rep. 2017, 19, 64. [Google Scholar] [CrossRef] [PubMed]
  14. Keilman, L.J. Seasonal Influenza (Flu). Nurs. Clin. N. Am. 2019, 54, 227–243. [Google Scholar] [CrossRef] [PubMed]
  15. Lau, J.T.; Griffiths, S.; Choi, K.C.; Tsui, H.Y. Widespread public misconception in the early phase of the H1N1 influenza epidemic. J. Infect. 2009, 59, 122–127. [Google Scholar] [CrossRef] [PubMed]
  16. Cox, M.M.J.; Izikson, R.; Post, P.; Dunkle, L.M. Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults. Ther. Adv. Vaccines 2015, 3, 97–108. [Google Scholar] [CrossRef] [PubMed]
  17. Watson, A.; Wilkinson, T.M.A. Respiratory viral infections in the elderly. Ther. Adv. Respir. Dis. 2021, 15, 175346662199505. [Google Scholar] [CrossRef]
  18. Capri, S.; Barbieri, M.; de Waure, C.; Boccalini, S.; Panatto, D. Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population. Hum. Vaccines Immunother. 2018, 14, 1331–1341. [Google Scholar] [CrossRef]
  19. Rosano, A.; Bella, A.; Gesualdo, F.; Acampora, A.; Pezzotti, P.; Marchetti, S.; Ricciardi, W.; Rizzo, C. Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013/14–2016/17 seasons). Int. J. Infect. Dis. 2019, 88, 127–134. [Google Scholar] [CrossRef]
  20. Xie, Y.; Bowe, B.; Maddukuri, G.; Al-Aly, Z. Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with COVID-19 and seasonal influenza: Cohort study. BMJ 2020, 371, m4677. [Google Scholar] [CrossRef]
  21. Manabe, T.; Fujikura, Y.; Mizukami, K.; Akatsu, H.; Kudo, K. Pneumonia-associated death in patients with dementia: A systematic review and meta-analysis. PLoS ONE 2019, 14, e0213825. [Google Scholar] [CrossRef]
  22. Darvishian, M.; Gefenaite, G.; Turner, R.M.; Pechlivanoglou, P.; Van der Hoek, W.; Heuvel, E.R.V.D.; Hak, E. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. J. Clin. Epidemiol. 2014, 67, 734–744. [Google Scholar] [CrossRef] [PubMed]
  23. Kissling, E.; Valenciano, M.; Cohen, J.M.; Oroszi, B.; Barret, A.-S.; Rizzo, C.; Stefanoff, P.; Nunes, B.; Pitigoi, D.; Larrauri, A.; et al. I-MOVE multi-centre case control study 2010-11: Overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS ONE 2011, 6, e27622. [Google Scholar] [CrossRef] [PubMed]
  24. Rondy, M.; Puig-Barberà, J.; Launay, O.; Duval, X.; Castilla, J.; Guevara, M.; Costanzo, S.; Donati, K.D.G.; Moren, A. 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: Pooled analysis from a European network of hospitals. A pilot study. PLoS ONE 2013, 8, e59681. [Google Scholar] [CrossRef]
  25. Marano, G.; Boracchi, P.; Luconi, E.; Pariani, E.; Pellegrinelli, L.; Galli, C.; Gandolfi, C.E.; Magoni, M.; Piro, A.; Scarcella, C.; et al. Evaluation of influenza vaccination efficacy in reducing influenza-related complications and excess mortality in Northern Italy (2014–2017). Expert Rev. Vaccines 2021, 20, 73–81. [Google Scholar] [CrossRef] [PubMed]
  26. Braeye, T.; Cornelissen, L.; Catteau, L.; Haarhuis, F.; Proesmans, K.; De Ridder, K.; Djiena, A.; Mahieu, R.; De Leeuw, F.; Dreuw, A.; et al. Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January–June 2021. Vaccine 2021, 39, 5456–5460. [Google Scholar] [CrossRef]
  27. Ng, O.T.; Koh, V.; Chiew, C.J.; Marimuthu, K.; Thevasagayam, N.M.; Mak, T.M.; Chua, J.K.; Ong, S.S.H.; Lim, Y.K.; Ferdous, Z.; et al. Impact of delta variant and vaccination on SARS-CoV-2 secondary attack rate among household close contacts. Lancet Reg. Health-West. Pac. 2021, 17, 100299. [Google Scholar] [CrossRef]
  28. Bruno, F.; Malvaso, A.; Chiesi, F.; Laganà, V.; Servidio, R.; Isella, V.; Ferrarese, C.; Gottardi, F.; Stella, E.; Agosta, F.; et al. COVID-19 vaccine uptake among family caregivers of people with dementia: The role of attitudes toward vaccination, perceived social support and personality traits. Front. Psychol. 2022, 13, 923316. [Google Scholar] [CrossRef] [PubMed]
  29. Franchi, C.; Arosio, F.; Djade, C.D.; Porro, G.S.; Nobili, A. Caregivers’ perceptions of the therapeutic benefits of drug treatments for dementia. Aging Clin. Exp. Res. 2013, 25, 677–683. [Google Scholar] [CrossRef]
  30. Ajzen, I. From intentions to actions: A theory of planned behavior. In Action Control; Kuhl, J., Beckmann, J., Eds.; Springer: Berlin/Heidelberg, Germany, 1985; pp. 11–39. ISBN 978-3-642-69748-7. [Google Scholar]
  31. Chu, A.; Gupta, V.; Unni, E.J. Utilizing the theory of planned behavior to determine the intentions to receive the influenza vaccine during COVID-19: A cross-sectional survey of US adults. Prev. Med. Rep. 2021, 23, 101417. [Google Scholar] [CrossRef]
  32. Juraskova, I.; O’brien, M.; Mullan, B.; Bari, R.; Laidsaar-Powell, R.; McCaffery, K. HPV vaccination and the effect of information framing on intentions and behaviour: An application of the theory of planned behaviour and moral norm. Int. J. Behav. Med. 2011, 19, 518–525. [Google Scholar] [CrossRef]
  33. Ajzen, I. The Theory of Planned Behavior. Organ. Behav. Hum. Decis. Process. 1991, 50, 179–211. [Google Scholar] [CrossRef]
  34. Servidio, R.; Malvaso, A.; Vizza, D.; Valente, M.; Campagna, M.R.; Iacono, M.L.; Martin, L.R.; Bruno, F. The intention to get COVID-19 vaccine and vaccine uptake among cancer patients: An extension of the theory of planned behaviour (TPB). Support. Care Cancer 2022, 30, 7973–7982. [Google Scholar] [CrossRef] [PubMed]
  35. Myers, L.B.; Goodwin, R. Determinants of adults’ intention to vaccinate against pandemic swine flu. BMC Public Health 2011, 11, 15. [Google Scholar] [CrossRef] [PubMed]
  36. Shmueli, L. Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model. BMC Public Health 2021, 21, 804. [Google Scholar] [CrossRef]
  37. Gallagher, S.; Povey, R. Determinants of older adults’ intentions to vaccinate against influenza: A theoretical application. J. Public Health 2006, 28, 139–144. [Google Scholar] [CrossRef] [PubMed]
  38. Agarwal, V. A/H1N1 vaccine intentions in college students: An application of the theory of planned behavior. J. Am. Coll. Health 2014, 62, 416–424. [Google Scholar] [CrossRef] [PubMed]
  39. Mongeau, P.A.; Liu, Y.; Hashi, E.C.; Roberto, A.J. College students’ influenza vaccine hesitation: A reasoned action investigation with quantitative and qualitative data. J. Behav. Med. 2022, 46, 65–75. [Google Scholar] [CrossRef]
  40. Greyson, D.; Dubé, È.; Fisher, W.A.; Cook, J.; Sadarangani, M.; Bettinger, J.A. Understanding influenza vaccination during pregnancy in Canada: Attitudes, norms, intentions, and vaccine uptake. Health Educ. Behav. 2021, 48, 680–689. [Google Scholar] [CrossRef]
  41. Ball, H.; Wozniak, T.R.; Kuchenbecker, C.M. Shot talk: Development and pilot test of a theory of planned behavior campaign to combat college student COVID-19 vaccine hesitancy. J. Health Commun. 2023, 28, 82–90. [Google Scholar] [CrossRef]
  42. Fishbein, M.; Ajzen, I. Predicting and Changing Behavior; Psychology Press: London, UK, 2011; ISBN 978-1-136-87473-4. [Google Scholar]
  43. Ouellette, J.A.; Wood, W. Habit and intention in everyday life: The multiple processes by which past behavior predicts future behavior. Psychol. Bull. 1998, 124, 54–74. [Google Scholar] [CrossRef]
  44. Wu, A.M.; Lau, J.T.; Ma, Y.-L.; Cheng, K.-M.; Lau, M.M. A longitudinal study using parental cognitions based on the theory of planned behavior to predict childhood influenza vaccination. J. Infect. Public Health 2020, 13, 970–979. [Google Scholar] [CrossRef] [PubMed]
  45. Mattson, M.P. Pathways towards and away from Alzheimer’s disease. Nature 2004, 430, 631–639. [Google Scholar] [CrossRef] [PubMed]
  46. Dardalas, I.; Pourzitaki, C.; Manomenidis, G.; Malliou, F.; Galanis, P.; Papazisis, G.; Kouvelas, D.; Bellali, T. Predictors of influenza vaccination among elderly: A cross-sectional survey in Greece. Aging Clin. Exp. Res. 2019, 32, 1821–1828. [Google Scholar] [CrossRef]
  47. Nagata, J.M.; Hernández-Ramos, I.; Kurup, A.S.; Albrecht, D.; Vivas-Torrealba, C.; Franco-Paredes, C. Social determinants of health and seasonal influenza vaccination in adults ≥ 65 years: A systematic review of qualitative and quantitative data. BMC Public Health 2013, 13, 388. [Google Scholar] [CrossRef] [PubMed]
  48. Piccirillo, B.; Gaeta, T. Survey on use of and attitudes toward influenza vaccination among emergency department staff in a New York metropolitan hospital. Infect. Control Hosp. Epidemiol. 2006, 27, 618–622. [Google Scholar] [CrossRef] [PubMed]
  49. Bruno, F.; Laganà, V.; Di Lorenzo, R.; Bruni, A.C.; Maletta, R. Calabria as a genetic isolate: A model for the study of neurodegenerative diseases. Biomedicines 2022, 10, 2288. [Google Scholar] [CrossRef]
  50. Bruno, F.; Laganà, V.; Pistininzi, R.; Tarantino, F.; Martin, L.; Servidio, R. Validation and psychometric properties of the Italian Vaccination Attitudes Examination (VAX-I) scale. Curr. Psychol. 2022, 1–11. [Google Scholar] [CrossRef]
  51. Paul, E.; Steptoe, A.; Fancourt, D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg. Health Eur. 2021, 1, 100012. [Google Scholar] [CrossRef]
Table 1. Demographic characteristics of family caregivers.
Table 1. Demographic characteristics of family caregivers.
VariableCategoriesFrequencyPercentage
Age, mean (SD) 55.9 (12.5)--
GenderMales2129.6
Females5070.4
Marital status Single811.3
In a relationship6388.7
Education Low (<13 years)4766.2
High (>13 years)2433.8
OccupationEmployed3346.5
Unemployed3853.5
Economic conditionsExtremely problematic22.8
Some problems1521.1
Standard conditions3954.9
Medium–high 1521.1
Table 2. Demographics and clinical characteristics of patients.
Table 2. Demographics and clinical characteristics of patients.
VariableCategoriesFrequencyPercentage
Age, mean (SD)75.5 (10.4)--
GenderMales2028.2
Females5171.8
Marital StatusSingle2852.5
In a relationship4347.8
EducationLow (<13 years)6591.5
High (>13 years) 68.5
DiagnosisAlzheimer’s Disease (AD) 4867.6
Frontotemporal Dementia (FTD)1216.9
Dementia with Lewy bodies (DLB)22.8
Vascular Dementia (VD)68.5
Mixed (AD + VD)34.2
Disease stageLow grade912.7
Moderate3853.5
Severe2433.8
Table 3. Correlation matrix with all potential predictor variables.
Table 3. Correlation matrix with all potential predictor variables.
1234567
1Intention to receive seasonal influenza vaccine
2Mistrust of vaccine benefit0.227 0.1520.133
3Worries about unforeseen future effects−0.125−0.043 0.1710.071
4Concerns about commercial profiteering−0.285 *−0.299 *0.537 *** −0.109−0.062
5Preference for natural immunity−0.070−0.275 *0.387 ***0.596 ***0.0210.02
6Subjective norms 0.323 **0.1520.171−0.1090.021
7Perceived behavior control0.362 **0.1330.071−0.0620.020.189
8Past vaccination behavior 0.373 **0.013−0.003−0.065−0.0120.0310.194
Note: * Significant at 0.05 level. ** Significant at 0.01 level. *** Significant at 0.001. Pearson correlations were used for associations between one continuous and one dichotomous variables; phi coefficient was used for the association between two dichotomous variables.
Table 4. Hierarchical binary logistic regression analysis with intention to receive a seasonal influenza vaccine as outcome variable.
Table 4. Hierarchical binary logistic regression analysis with intention to receive a seasonal influenza vaccine as outcome variable.
PredictorsβSE βOdds RatioZWald Statisticdfp-Value95% CI
Upper Lower
Model 1
Concerns about commercial profiteering−0.310.140.73−2.207.4710.0280.550.96
Subjective norms 0.240.111.272.085.7810.0381.011.61
Perceived behavioral control 0.500.211.662.3810.2310.0171.092.51
Model 2
Concerns about commercial profiteering−0.290.140.74−2.036.4210.0420.550.99
Subjective norms 0.220.111.252.035.2110.0431.001.56
Perceived behavioral control 0.480.221.622.187.6710.0291.052.50
Past seasonal influenza vaccine behavior 0.820.412.281.994.5210.0471.015.13
Model 1: Deviance = 38.4, AIC = 46.4, BIC = 55.4, McFadden’s Pseudo R2 = 0.405, Cox and Snell R2 = 0.308. Nagelkerke R2 = 0.516, Overall model test χ2 = 26.1 (df = 3, p < 0.001). Model 2: Deviance = 33.8, AIC = 43.8, BIC = 55.2, McFadden’s Pseudo R2 = 0.475, Cox and Snell R2 = 0.351. Nagelkerke R2 = 0.588, Overall model test χ2 = 30.7 (df = 4, p < 0.001).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bruno, F.; Abondio, P.; Laganà, V.; Colao, R.; Curcio, S.M.; Frangipane, F.; Puccio, G.; Di Lorenzo, R.; Bruni, A.C.; Maletta, R. Using the Theory of Planned Behavior and Past Behavior to Explain the Intention to Receive a Seasonal Influenza Vaccine among Family Caregivers of People with Dementia. Int. J. Transl. Med. 2023, 3, 246-254. https://doi.org/10.3390/ijtm3020017

AMA Style

Bruno F, Abondio P, Laganà V, Colao R, Curcio SM, Frangipane F, Puccio G, Di Lorenzo R, Bruni AC, Maletta R. Using the Theory of Planned Behavior and Past Behavior to Explain the Intention to Receive a Seasonal Influenza Vaccine among Family Caregivers of People with Dementia. International Journal of Translational Medicine. 2023; 3(2):246-254. https://doi.org/10.3390/ijtm3020017

Chicago/Turabian Style

Bruno, Francesco, Paolo Abondio, Valentina Laganà, Rosanna Colao, Sabrina M. Curcio, Francesca Frangipane, Gianfranco Puccio, Raffaele Di Lorenzo, Amalia C. Bruni, and Raffaele Maletta. 2023. "Using the Theory of Planned Behavior and Past Behavior to Explain the Intention to Receive a Seasonal Influenza Vaccine among Family Caregivers of People with Dementia" International Journal of Translational Medicine 3, no. 2: 246-254. https://doi.org/10.3390/ijtm3020017

Article Metrics

Back to TopTop